A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)

Clinical trial NCT02147938 · COMPLETED

Trial details

NCT number: NCT02147938
Sponsor: Astellas Pharma S.A.S.
Status: COMPLETED
Study type: OBSERVATIONAL

Renal Transplantation

Start date: 2014-07-17
Primary completion: 2017-05-15
Enrollment: 578

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.